MI - Nursing Case Study

Pathophysiology

• Primary mechanism: Coronary artery occlusion due to atherosclerotic plaque rupture leads to an acute reduction in myocardial blood supply, causing ischemia and necrosis of cardiac tissue.

• Secondary mechanism: Ischemia triggers a cascade of cellular events, including ATP depletion and loss of ion homeostasis, resulting in impaired contractility and arrhythmias.

• Key complication: Prolonged ischemia can lead to heart failure and life-threatening arrhythmias, such as ventricular fibrillation, due to extensive myocardial damage and scar formation.

Patient Profile

Demographics:

58-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia, Chronic Kidney Disease Stage 3

• Current medications: Lisinopril, Metformin, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe chest pain radiating to the left arm and jaw

• Key symptoms: Shortness of breath, profuse sweating, nausea, dizziness

• Vital signs: Blood pressure 90/60 mmHg, heart rate 120 bpm, respiratory rate 28 breaths per minute, oxygen saturation 88% on room air, temperature 99.1°F

Section 1

Initial assessment findings revealed significant concerns necessitating immediate intervention. The patient was diaphoretic and appeared in acute distress, with evident pallor indicating compromised perfusion. His jugular venous distension suggested possible right-sided heart failure, and auscultation revealed diminished breath sounds with crackles at the lung bases, indicative of pulmonary congestion. The electrocardiogram (ECG) showed ST-segment elevation in leads II, III, and aVF, consistent with an inferior wall myocardial infarction.

Blood work returned with critical values: Troponin I levels were markedly elevated at 12 ng/mL, confirming myocardial injury, and B-type Natriuretic Peptide (BNP) was elevated at 1200 pg/mL, suggesting significant heart failure. Additionally, his serum potassium was 5.8 mEq/L, posing a risk for arrhythmias, and his blood glucose was elevated at 280 mg/dL, complicating his metabolic status. The estimated glomerular filtration rate had declined to 25 mL/min/1.73m², indicating worsening renal function.

In response to these findings, the medical team initiated dual antiplatelet therapy, anticoagulation, and vasopressors to support blood pressure. However, shortly after, the patient developed ventricular fibrillation, necessitating immediate defibrillation and advanced cardiac life support measures. This acute change in status underscored the critical nature of his condition and raised concerns for further complications, such as cardiogenic shock and multi-organ dysfunction, requiring intensive monitoring and comprehensive care planning.

Section 2

As the patient's condition stabilized momentarily post-defibrillation, new complications arose, demanding further critical interventions. Despite the initial success in restoring a sinus rhythm, the patient's blood pressure remained precariously low, with readings averaging 78/50 mmHg, indicative of cardiogenic shock. The medical team promptly adjusted the vasopressor regimen, increasing the dosage of norepinephrine and adding dobutamine to enhance cardiac output. However, the patient's urine output dwindled to less than 20 mL/hour, signaling acute kidney injury progression. Repeat renal function tests revealed a further decline in eGFR to 18 mL/min/1.73m², raising the specter of impending renal failure.

In parallel, the patient exhibited signs of respiratory compromise, with oxygen saturation levels dropping to 88% on a non-rebreather mask. Arterial blood gas analysis showed a pH of 7.28, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg, consistent with respiratory acidosis and hypoxemia. The crackles in the lung bases had progressed to involve all lung fields, suggesting worsening pulmonary edema. These findings necessitated the transition to non-invasive positive pressure ventilation (NIPPV) to improve oxygenation and decrease the work of breathing.

The complexity of this clinical scenario demanded a multidisciplinary approach, involving nephrology for potential renal replacement therapy and pulmonology for advanced respiratory support strategies. The intersection of cardiogenic shock, acute kidney injury, and respiratory failure posed a formidable challenge, necessitating continuous hemodynamic monitoring, diligent assessment of fluid status, and careful titration of supportive therapies. The team remained vigilant for further complications, such as systemic inflammatory response syndrome (SIRS) and potential multi-organ dysfunction syndrome (MODS), requiring preparedness for rapid intervention and adjustment of the treatment plan.

Section 3

As the medical team continued their vigilant monitoring, new diagnostic results provided critical insights into the evolving clinical picture. A repeat echocardiogram revealed significant left ventricular dysfunction with an ejection fraction now reduced to 25%, indicating severe systolic heart failure. This finding correlated with the patient's ongoing hypotension and poor response to the current vasopressor and inotropic therapy. Additionally, a chest X-ray confirmed the progression of bilateral pulmonary edema, with diffuse alveolar infiltrates now extending throughout both lung fields, further complicating respiratory management. Blood cultures, drawn due to a rising concern of potential infection, returned positive for gram-negative bacilli, necessitating the initiation of broad-spectrum antibiotics to address a possible septic component contributing to the patient's instability.

Despite the escalation of interventions, the patient's clinical status continued to deteriorate, with the development of worsening metabolic acidosis. A repeat arterial blood gas analysis revealed a pH of 7.22, a PaCO2 of 60 mmHg, and a bicarbonate level of 15 mEq/L, indicating a mixed respiratory and metabolic acidosis. The lactate level had risen to 6 mmol/L, suggestive of tissue hypoperfusion and an inadequate response to circulatory support. The nephrology team, having assessed the rapidly declining renal function and the overall clinical trajectory, recommended the initiation of continuous renal replacement therapy (CRRT) to manage fluid overload and acid-base disturbances while avoiding hemodynamic instability associated with intermittent hemodialysis.

Given the patient's tenuous condition, the intensivist suggested exploring mechanical circulatory support options, such as intra-aortic balloon pump (IABP) insertion, to provide ventricular unloading and improved coronary perfusion. The interdisciplinary team, aware of the critical balance between aggressive intervention and the risk of further destabilizing the patient, prepared for the potential escalation of care. The overarching goal remained to stabilize the patient sufficiently to allow for recovery of organ function, while maintaining a readiness to address any new complications that might arise in this complex and rapidly evolving clinical scenario.

Section 4

As the medical team continued to navigate the intricate clinical landscape, a significant change in the patient's status emerged. Despite the initiation of continuous renal replacement therapy (CRRT) and broad-spectrum antibiotics, the patient's hemodynamic instability persisted, necessitating further escalation in circulatory support. The insertion of an intra-aortic balloon pump (IABP) was performed successfully, yet the anticipated hemodynamic improvements were marginal. The patient's blood pressure remained critically low at 85/50 mmHg, and heart rate fluctuated between bradycardia and tachycardia, suggesting autonomic instability and further complicating the management plan.

New laboratory results painted an even grimmer picture. The white blood cell count had surged to 20,000/mm³, accompanied by a left shift, indicating a mounting inflammatory response. Simultaneously, liver function tests showed a marked elevation in transaminases, with an AST of 180 U/L and ALT of 150 U/L, raising concerns about hepatic congestion or ischemia due to impaired cardiac output. The patient's coagulation profile revealed a prolonged prothrombin time (PT) and an elevated international normalized ratio (INR) of 2.5, suggestive of developing disseminated intravascular coagulation (DIC), a potential consequence of the ongoing sepsis and multi-organ dysfunction.

With these new complications, the interdisciplinary team faced critical decisions. The challenge lay in balancing aggressive intervention against the potential for exacerbating the patient's frail condition. The intensivist proposed a trial of low-dose corticosteroids to potentially modulate the septic response, while the cardiologist considered transitioning to a more advanced mechanical circulatory support, such as a ventricular assist device (VAD), if the patient's condition permitted stabilization. The team remained vigilant, fully aware that each decision carried significant risks but also the possibility of halting the downward spiral and providing a window of opportunity for recovery.

Section 5

As the team continued to monitor the patient's status closely, a change in the patient's neurologic condition became evident. The patient, who had previously been responsive and oriented, now exhibited signs of altered mental status, including confusion and intermittent unresponsiveness. The Glasgow Coma Scale (GCS) score decreased from 15 to 10, raising concerns about potential cerebral hypoperfusion or septic encephalopathy. This new development prompted an urgent need for neuroimaging to rule out an acute cerebrovascular event, given the context of hemodynamic instability and possible embolic phenomena secondary to impaired cardiac function.

Simultaneously, repeat laboratory tests revealed a further deterioration in renal function, with serum creatinine levels climbing to 3.5 mg/dL, exacerbating the existing renal impairment despite ongoing CRRT. The patient's lactate levels also increased to 6 mmol/L, indicating worsening tissue hypoperfusion and a heightened state of metabolic acidosis. The arterial blood gas analysis showed a pH of 7.28, with a bicarbonate level of 16 mEq/L, underscoring the complexity of managing concurrent respiratory and metabolic derangements.

The team confronted a crossroads, realizing that the patient's multisystem involvement necessitated a reevaluation of the therapeutic approach. Consideration of advanced mechanical support, such as transitioning to a VAD, was revisited, but the patient's neurological decline posed additional challenges regarding candidacy for such interventions. The intensivist weighed the potential benefits of corticosteroid therapy against the risk of further immunosuppression in a patient already battling severe sepsis. Each decision required meticulous deliberation, as the window for effective intervention was narrowing, demanding the team's collective expertise to navigate the impending critical turning point.